These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37995797)

  • 1. Reply of the Authors: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
    Witz CA; Doody KJ; Park JK; Daftary GS; Heiser PW
    Fertil Steril; 2024 Feb; 121(2):359. PubMed ID: 37995797
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
    Batista AR; Schwarze JE; Lispi M
    Fertil Steril; 2024 Feb; 121(2):358. PubMed ID: 37734649
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.
    Witz CA; Daftary GS; Doody KJ; Park JK; Seifu Y; Yankov VI; Heiser PW;
    Fertil Steril; 2020 Aug; 114(2):321-330. PubMed ID: 32416978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial.
    European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone
    Fertil Steril; 2002 Sep; 78(3):520-8. PubMed ID: 12215327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Arce JC; Andersen AN; Fernández-Sánchez M; Visnova H; Bosch E; García-Velasco JA; Barri P; de Sutter P; Klein BM; Fauser BC
    Fertil Steril; 2014 Dec; 102(6):1633-40.e5. PubMed ID: 25256937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial.
    Polyzos NP; Camus M; Llacer J; Pantos K; Tournaye H
    BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial.
    Robins JC; Khair AF; Widra EA; Alper MM; Nelson WW; Foster ED; Sinha A; Ando M; Heiser PW; Daftary GS
    F S Rep; 2020 Dec; 1(3):257-263. PubMed ID: 34223253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction.
    Lloyd A; Kennedy R; Hutchinson J; Sawyer W
    Fertil Steril; 2003 Nov; 80(5):1108-13. PubMed ID: 14607557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection.
    Esteves SC; Schertz JC; Verza S; Schneider DT; Zabaglia SF
    Reprod Biol Endocrinol; 2009 Oct; 7():111. PubMed ID: 19828024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seminal anti-Müllerian hormone levels during recombinant human follicle-stimulating hormone treatment in men with idiopathic infertility undergoing assisted reproduction cycles.
    Caprio F; De Franciscis P; Trotta C; Ianniello R; Mele D; Colacurci N
    Andrology; 2015 Sep; 3(5):843-7. PubMed ID: 26223208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.
    Ishihara O; Klein BM; Arce JC;
    Fertil Steril; 2021 Jun; 115(6):1478-1486. PubMed ID: 33272623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Kim CH; Kim SR; Cheon YP; Kim SH; Chae HD; Kang BM
    Fertil Steril; 2009 Dec; 92(6):2082-4. PubMed ID: 19589522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison.
    Ji Z; Quan X; Lan Y; Zhao M; Tian X; Yang X
    Curr Ther Res Clin Exp; 2020; 92():100572. PubMed ID: 31908689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of recombinant follicle stimulating hormone in a woman with allergic reaction to menotropin: a case report.
    Harrison S; Wolf T; Abuzeid MI
    Gynecol Endocrinol; 2000 Jun; 14(3):149-52. PubMed ID: 10923273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT.
    Ebrahimi M; Akbari-Asbagh F; Ghalandar-Attar M
    Int J Reprod Biomed; 2017 Feb; 15(2):101-108. PubMed ID: 28462402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
    Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
    Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Recombinant Human Follicle-Stimulating Hormone on Sperm Quality, Chromatin Status and Clinical Outcomes of Infertile Oligozoospermic Men Candidate for Intracytoplasmic Sperm Injection: A Randomized Clinical Trial.
    Verdi A; Nasr-Esfahani MH; Forouzanfar M; Tavalaee M
    Int J Fertil Steril; 2021 Jan; 15(1):1-7. PubMed ID: 33497040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.